Rznomics

476830· KOSDAQ· Health Care· Pharmaceuticals, Biotechnology & Life Sciences

₩26,900-2.54%

2026-09-18

Financials

Valuation Metrics

Rznomics's Market Cap is ₩7547B. At end of 2025 it was ₩2.3T. Ranked #356 of 2,421 in KR market (top 15%), #111 of 1,640 on KOSDAQ (top 7%), #39 of 231 in Pharmaceuticals, Biotechnology & Life Sciences (top 17%) by Market Cap.

Investment Metrics(as of 2026-09-18)

Metric	Value	Rank
Size
Market Cap	754.69B KRW	KR#356/2,421 Sec#39/231
Revenue	2.00B KRW	KR#2,382/2,421 Sec#215/231
Net Income	-27.61B KRW	KR—/2,421 Sec—/231
Total Assets	51.56B KRW	KR#2,195/2,421 Sec#197/231
Net Assets	46.61B KRW	KR#1,955/2,421 Sec#165/231
Value
P/B	16.19x	KR#2,398/2,421 Sec#221/231
P/S	376.64x	KR#2,406/2,421 Sec#221/231
FCF Yield	-1.44%	KR—/2,421 Sec—/231
Profitability
ROE	-59.24%	KR#2,297/2,421 Sec#203/231
ROA	-53.55%	KR#2,369/2,421 Sec#217/231
Op. Margin	-1418.93%	KR#2,386/2,421 Sec#218/231
Financial Health
Debt Ratio	10.62%	KR#159/2,421 Sec#32/231
FCF	-10.90B KRW	KR#1,733/2,421 Sec#152/231
Cash	6.85B KRW	KR#1,888/2,421 Sec#169/231
Current Ratio	9.68x	KR#103/2,421 Sec#23/231
Performance
1M Return	-14.87%	KR#2,238/2,421 Sec#190/231
From 52W High	-78.06%	KR#2,323/2,421 Sec#211/231
1Y MDD	-82.54%	KR#2,335/2,421 Sec#221/231
Trading
Volume	209,300 shares	KR#473/2,421 Sec#29/231
Trading Value	5.67B KRW	KR#348/2,421 Sec#32/231
Foreign Own.	9.29%	KR#503/2,421 Sec#42/231
Per Share
EPS	-984 KRW	KR—/2,421 Sec—/231
BPS	1,661 KRW	KR#2,149/2,421 Sec#181/231